Temodar Related Clinical Trials
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Active, not recruiting]
Sarasar and Temodar for Glioblastoma Multiforme Patients [Active, not recruiting]
Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors [Completed]
A Phase I/II Study of TPI 287 - Temozolomide Combination in Melanoma [Recruiting]
Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma [Completed]
Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas [Completed]
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) [Terminated]
Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM [Completed]
Taxotere/Temodar/Cisplatin Study in Melanoma Patients [Completed]
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma [Completed]
Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma [Not yet recruiting]
Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients [Recruiting]
Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma [Completed]
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062) [Active, not recruiting]
Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors [Completed]
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas [Completed]
DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis [Terminated]
Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme [Completed]
WEE1 Inhibitor MK-1775, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme [Recruiting]
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma [Completed]
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Completed]
Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas [Completed]
Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors [Active, not recruiting]
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients [Active, not recruiting]
Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM [Active, not recruiting]
Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors [Recruiting]
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas [Recruiting]
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma [Active, not recruiting]
Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM [Completed]
Temodar and Sutent as Therapy for Melanoma [Terminated]
ABT-888 and Temozolomide for Liver Cancer [Active, not recruiting]
Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas [Completed]
BMN-673 and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies [Recruiting]
Temozolomide in Treating Patients With Recurrent High-Grade Glioma [Completed]
Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas [Completed]
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2) [Completed]
Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma [Recruiting]
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [Active, not recruiting]
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma [Suspended]
Biochemotherapy With Temozolomide for Metastatic Melanoma [Terminated]
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery [Active, not recruiting]
Doxycycline, Temozolomide and Ipilimumab in Melanoma [Completed]
Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM [Terminated]
Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma [Completed]
Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain [Completed]
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma [Recruiting]
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma [Terminated]
High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma [Active, not recruiting]
Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma [Active, not recruiting]
A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma [Active, not recruiting]
Ipilimumab + Temozolomide in Metastatic Melanoma [Active, not recruiting]
Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma [Active, not recruiting]
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients [Completed]
Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway [Recruiting]
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients [Withdrawn]
Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases [Active, not recruiting]
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma [Recruiting]
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas [Recruiting]
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide [Completed]
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma [Terminated]
Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment [Completed]
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma [Completed]
Temozolomide in Treating Patients With Low-Grade Glioma [Completed]
Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases [Completed]
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children [Recruiting]
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer [Active, not recruiting]
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma [Active, not recruiting]
Phase I Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin for Post-Radiation Therapy (RT) Glioblastoma Multiforme (GBM) [Recruiting]
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies [Recruiting]
A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer [Completed]
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma [Recruiting]
RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors [Active, not recruiting]
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors [Recruiting]
Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) [Terminated]
Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer [Completed]
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System [Completed]
Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration [Recruiting]
Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial [Recruiting]
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [Completed]
Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) [Active, not recruiting]
Study of Temozolomide to Treat Newly Diagnosed Brain Metastases [Terminated]
Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme [Terminated]
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye [Active, not recruiting]
Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma [Completed]
Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy [Terminated]
Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme [Active, not recruiting]
Veliparib and Temozolomide in Treating Patients With Acute Leukemia [Active, not recruiting]
Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma [Recruiting]
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy [Not yet recruiting]
Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma [Completed]
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572) [Completed]
|